Cargando…

A mixed methods study of HIV-related services in buprenorphine treatment

BACKGROUND: Opioid use disorder (OUD) is a major risk factor in the acquisition and transmission of HIV. Clinical practice guidelines call for the integration of HIV services in OUD treatment. This mixed methods study describes the integration of HIV services in buprenorphine treatment and examines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knudsen, Hannah K., Cook, Jennifer, Lofwall, Michelle R., Walsh, Sharon L., Studts, Jamie L., Havens, Jennifer R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559779/ https://www.ncbi.nlm.nih.gov/pubmed/28814313 http://dx.doi.org/10.1186/s13011-017-0122-5

Ejemplares similares

Recent Increase in Methamphetamine Use in a Cohort of Rural People Who Use Drugs: Further Evidence for the Emergence of Twin Epidemics
por: Havens, Jennifer R., et al.
Publicado: (2022)

Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl
por: D’Onofrio, Gail, et al.
Publicado: (2023)

Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C
por: Havens, Jennifer R, et al.
Publicado: (2021)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Adaptation of a standard extended-release naltrexone (XR-NTX) protocol for rural re-entering offenders with OUD
por: Staton, Michele, et al.
Publicado: (2021)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
por: Chavan, Niraj R., et al.
Publicado: (2017)

Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections
por: Fanucchi, Laura C., et al.
Publicado: (2022)

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements
por: Silwal, Anita, et al.
Publicado: (2023)

Using User-Centered Design to Facilitate Adherence to Annual Lung Cancer Screening: Protocol for a Mixed Methods Study for Intervention Development
por: Hirsch, Erin A, et al.
Publicado: (2023)

Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022)

1635. Do Persons With Opioid Use Disorder and Injection-Related Infections Really Need Prolonged Hospitalizations to Complete Intravenous Antibiotic Therapy?
por: Fanucchi, Laura, et al.
Publicado: (2018)

Gestational Buprenorphine Exposure Disrupts Dopamine Neuron Activity and Related Behaviors in Adulthood
por: Elam, Hannah B., et al.
Publicado: (2022)

Priorities for improvement across cancer and non-cancer related preventive services among rural and non-rural clinicians
por: Brtnikova, Michaela, et al.
Publicado: (2022)

Physicians’ satisfaction with providing buprenorphine treatment
por: Knudsen, Hannah K., et al.
Publicado: (2019)

Evaluation of tradipitant, a selective NK1 antagonist, on response to oxycodone in humans
por: Coe, Marion A., et al.
Publicado: (2021)

Prevalence and predictors of suicidality among adults initiating office-based buprenorphine
por: Lent, Michelle R., et al.
Publicado: (2023)

Buprenorphine Exposure Alters the Development and Migration of Interneurons in the Cortex
por: Nieto-Estévez, Vanesa, et al.
Publicado: (2022)

Health service use among adults with cerebral palsy: a mixed methods systematic review protocol
por: Manikandan, Manjula, et al.
Publicado: (2020)

Cigarette Smoking Cessation Intervention for Buprenorphine Treatment Patients
por: Hall, Sharon M, et al.
Publicado: (2018)

Buprenorphine reverses neurocognitive impairment in EcoHIV infected mice: A potential therapy for HIV-NCI
por: Murphy, Aniella J., et al.
Publicado: (2022)

Buprenorphine
por: Mazurek, Jaroslaw, et al.
Publicado: (2014)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

A mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine in community-based care in England and Wales
por: Gibson, R., et al.
Publicado: (2021)

Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine
por: Bormann, Nicholas L., et al.
Publicado: (2023)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

1025. Integrating buprenorphine into an urban HIV primary care practice: Outcomes on viral load suppression and opioid use
por: Fabricant, Scott, et al.
Publicado: (2020)

Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
por: Jakubowski, Andrea, et al.
Publicado: (2022)

Drug Abuse Treatment Beyond Prison Walls
por: Leukefeld, Carl, et al.
Publicado: (2009)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners: The Impact of Buprenorphine Treatment
por: Springer, Sandra Ann, et al.
Publicado: (2010)

Transition from child to adult health services for young people with cerebral palsy in Ireland: a mixed-methods study protocol
por: Ryan, Jennifer M, et al.
Publicado: (2020)

Intolerance of sublingual buprenorphine-naloxone during induction in a patient with end-stage liver disease: A case report
por: Behan, Jennifer, et al.
Publicado: (2016)

Implementation strategies preferred by primary care clinicians to facilitate cancer prevention and control activities
por: Glasgow, Russell E., et al.
Publicado: (2023)

Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation
por: Lowry, Natalie, et al.
Publicado: (2022)

Buprenorphine Microdosing Cross Tapers: A Time for Change
por: Raheemullah, Amer, et al.
Publicado: (2022)

Emergency Department Clinicians’ Attitudes Toward Opioid Use Disorder and Emergency Department-initiated Buprenorphine Treatment: A Mixed-Methods Study
por: Im, Dana D., et al.
Publicado: (2020)

The Role of HIV-Related Stigma in Utilization of Skilled Childbirth Services in Rural Kenya: A Prospective Mixed-Methods Study
por: Turan, Janet M., et al.
Publicado: (2012)

Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
por: Furo, Hiroko, et al.
Publicado: (2021)

BUPRENORPHINE ABUSE : A CASE REPORT
por: Nizamie, S. Haque, et al.
Publicado: (1990)

Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats
por: Janganati, Venumadhav, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7rne8oop2mb5ujmnv02aos3ilj